Hereditary otorhinolaryngologic disease
MONDO:0018751An instance of otorhinolaryngologic disease that is caused by a modification of the individual's genome.
Also known as: genetic otorhinolaryngologic disease
102 clinical trials for this condition and its sub-types, 0 tagged with Hereditary otorhinolaryngologic disease itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Hereditary otorhinolaryngologic disease
-
Benign paroxysmal positional vertigo 18 trials
-
Meniere disease 16 trials
3 sub-types
- Active cochlear Meniere disease 0 trials
- Active cochleovestibular Meniere disease 0 trials
- Active vestibular Meniere disease 0 trials
-
Motion sickness 14 trials · 16 incl. sub-types
1 sub-type
- Space motion sickness 4 trials
-
Choanal atresia 4 trials
2 sub-types
- Choanal atresia, bilateral 0 trials
- Choanal atresia, unilateral 0 trials
-
Otosclerosis 4 trials
11 sub-types
- Congenital corneal opacities, cornea guttata, and corectopia 0 trials
- Otosclerosis 1 0 trials
- Otosclerosis 10 0 trials
- Otosclerosis 11 0 trials
- Otosclerosis 12 0 trials
- Otosclerosis 2 0 trials
- Otosclerosis 3 0 trials
- Otosclerosis 4 0 trials
- Otosclerosis 5 0 trials
- Otosclerosis 7 0 trials
- Otosclerosis 8 0 trials
-
Familial thyroglossal duct cyst 2 trials
-
BNAR syndrome 1 trial
-
Aural atresia, congenital 1 trial
-
Second branchial cleft anomaly 1 trial
-
Bifid nose, autosomal recessive 0 trials
1 sub-type
- Paramedian nasal cleft 0 trials
-
Familial nasal acilia 0 trials
-
Isolated congenital anosmia 0 trials
-
Nasal dermoid cyst 0 trials
-
Tonsillar lymphoma 0 trials
-
Tympanic paraganglioma 0 trials
-
Vertigo, benign recurrent, 1 0 trials
-
Can an antiviral drug protect hearing in infants with congenital CMV?
Disease control Stopped earlyThis trial tests whether the antiviral drug valganciclovir can improve hearing and language outcomes in infants who have hearing loss due to congenital cytomegalovirus (CMV) infection. Infants aged 1 to 12 months with confirmed sensorineural hearing loss will receive either valga…
Phase 2 • Sponsor: Albert Park • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
New stent aims to dry up tears after eye surgery
Symptom relief Stopped earlyThis study tested a redesigned lacrimal stent, called the Slit Stent II, for people with severe tearing (epiphora) caused by a blocked tear duct. The stent has slits to allow tears to drain while it is still in place after DCR surgery. The trial planned to enroll 5 people to chec…
Sponsor: Thomas Gardner • Aim: Symptom relief
Last updated Jun 27, 2026 09:08 UTC